Time to move forward from “first-generation” prognostic gene signatures in early breast cancer


For clinicians, it has been clear for many years that breast cancer patients with the same clinical and pathological characteristics can have diverse clinical outcomes. The advances in the annotations of the genome and the emergence of high throughput gene expression technologies during the last decade have offered researchers powerful means to investigate… (More)
DOI: 10.1007/s10549-010-1213-4


  • Presentations referencing similar topics